Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 17/20 | 0.61 |
| ▸ | PIK3CG | P48736 | 16/20 | 0.61 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.48 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14247403 | 1.00 | PI4KA (0.61) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| SCHEMBL30089076 | 1.00 | PI4KA (0.61) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| SCHEMBL14317917 | 0.93 | PIK3CG (0.67) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| SCHEMBL14247728 | 0.92 | PI4KA (0.55) | PI4KAPIK3CGPIK3CAPIK3CD | |
| SCHEMBL14247335 | 0.92 | PI4KA (0.56) | PI4KAPIK3CGPIK3CAPIK3CD | |
| SCHEMBL9960577 | 0.91 | PI4KA (0.74) | PI4KAPIK3CG | |
| SCHEMBL14247481 | 0.91 | PI4KA (0.55) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| SCHEMBL14247306 | 0.90 | PIK3CG (0.54) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| Formic Acid SCHEMBL14247532 | 0.90 | PIK3CG (0.63) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 | |
| SCHEMBL14247284 | 0.88 | PIK3CG (0.54) | PI4KAPIK3CGPIK3CAPIK3CDPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4059948-A1 | LIBRARY OF BARCODED EXTRACELLULAR VESICLES | The University of Tokyo (JP) | 2022-09-21 | — | — | EP | claimed |
| US-20240391942-A1 | HALOGENATED PHENYLARSINE OXIDE COMPOUND AND APPLICATION THEREOF | NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2024-11-28 | — | — | US | disclosed |
| CN-118103380-A | Halogenated benzene arsenic oxide compound and application thereof | 挪贝肽医药科技(上海)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20220411785-A1 | LIBRARY OF BARCODED EXTRACELLULAR VESICLES | THE UNIVERSITY OF TOKYO (JP) | 2022-12-29 | — | — | US | disclosed |
| EP-4059948-A1 | LIBRARY OF BARCODED EXTRACELLULAR VESICLES | The University of Tokyo (JP) | 2022-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391942-A1 | HALOGENATED PHENYLARSINE OXIDE COMPOUND AND APPLICATION THEREOF | SLCO2B1, SLCO2A1, SLCO1B1 | PI4KA 3755/4885PIK3CG 4211/4885PIK3CA 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.